Research focused on blood, brain, breast and colon cancers; improving awareness of the link between alcohol use and cancer risk; and clinical trials for high-risk prostate cancer and high-grade neuroendocrine neoplasms are among the projects that will benefit from $1.5 million in new grants announced by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Siteman Investment Program awards $1.5 million in cancer research grants
View Content